1.
Clin Transl Radiat Oncol
; 12: 16-20, 2018 Aug.
Article
in English
| MEDLINE
| ID: mdl-30073210
ABSTRACT
PATRIOT is a phase I study of the ATR inhibitor, AZD6738, as monotherapy, and in combination with palliative radiotherapy. Here, we describe the protocol for this study, which opened in 2014 and is currently recruiting and comprises dose escalation of both drug and radiotherapy, and expansion cohorts.